CDC and Mubadala take minority stake in Galileo Education

Tweet
Facebook
LinkedIn
Google plus
Send to

CDC International Capital and Mubadala Development have acquired a minority stake in private higher education group Galileo Global Education, joining main investor Providence Equity Partners.

Galileo is a portfolio company of Providence Equity – an American PE firm speicalised in media, communication and education investments.

In 2015, it helped Galileo acquire French higher education business Studialis in a deal valued at approximately €250m, representing a multiple higher than 10x the EBITDA, which was €19m at the time. Leverage on the deal was 5x EBITDA.

CDC did not disclose the value of its investment, but a source close to the matter told unquote" that "tens of millions" had been invested.

CDC and Mubadala's participation will help support Studialis's activity and development.

Company
Galileo is a higher education platform focused on Europe and Latin America.

It is owned by US-based Providence and operates five education brands: Atelier de Sèvres, Istituto Marangoni, LISAA, Macromedia and IEU.

Galileo is a post-secondary education group providing a total of 40,000 students with access to higher education in the fields of applied arts, design, communication and management in seven countries: France, Italy, the UK, Germany, Mexico, China and India.

People
CDC International Capital – Laurent Vigier (CEO).